Vertex Pharmaceuticals Incorporated (FRA:VX1)
333.45
-2.30 (-0.69%)
At close: Aug 15, 2025, 10:00 PM CET
Vertex Pharmaceuticals Employees
Vertex Pharmaceuticals had 6,100 employees as of December 31, 2024. The number of employees increased by 700 or 12.96% compared to the previous year.
Employees
6,100
Change (1Y)
700
Growth (1Y)
12.96%
Revenue / Employee
€1,593,952
Profits / Employee
€507,773
Market Cap
86.00B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6,100 | 700 | 12.96% |
Dec 31, 2023 | 5,400 | 600 | 12.50% |
Dec 31, 2022 | 4,800 | 900 | 23.08% |
Dec 31, 2021 | 3,900 | 500 | 14.71% |
Dec 31, 2020 | 3,400 | 400 | 13.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Siemens Energy AG | 98,000 |
Rheinmetall AG | 28,539 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Deutsche Bank Aktiengesellschaft | 89,753 |
Vertex Pharmaceuticals News
- 3 days ago - Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet - Seeking Alpha
- 4 days ago - Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade) - Seeking Alpha
- 5 days ago - Vertex Pharmaceuticals's Options Frenzy: What You Need to Know - Benzinga
- 8 days ago - 1.95M Reasons To Be Bullish On Vertex Pharmaceuticals Stock - Benzinga
- 8 days ago - Meet Reshma Kewalramani who joins the list of 100 Most Powerful People in Business 2025 alongside Jensen Huang, Sundar Pichai, and others - The Times of India
- 8 days ago - The RMR Group Announces $1.0 Billion Refinancing of Vertex Pharmaceuticals’ Headquarters in Boston Seaport District - Wallstreet:Online
- 9 days ago - Vertex Pharmaceuticals Unusual Options Activity - Benzinga
- 10 days ago - 7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip - The Motley Fool